Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pedro Roda-Navarro has a total of 129 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Slingshot-1 (SSH1) phosphatase Controls Cytoskeletal Remodeling, Integrin conformation and Metabolic Reprogramming During CD4 T Cell Activation

    by Noa Martí, Alvaro Gómez-Morón, Marta Lozano-Prieto, Camila Scagnetti, Carlos Carrasco-Padilla, Lidia Marín-Algeciras, Óscar Aguilar-Sopeña, Francisco Francisco, Pedro Roda-Navarro

    Effective T cell activation requires formation of the immunological synapse (IS), which depends on coordinated remodeling of actin and microtubule cytoskeletons. Upon T cell receptor (TCR) engagement, the phosphatase Slingshot-1 (SSH1) is rapidly recruited to the nascent IS, where it dephosphorylates cofilin and suppresses LIM kinase activity to promote actin dynamics. However, the mechanism by which SSH1 anchors at and controls IS formation is unknown. Here, we identify the role of SSH1 in assembling a protein hub with Talin-1, Kindlin-3, ADAP, and Myosin IIA that promotes high-affinity activation of the integrin LFA-1. This allows SSH1 to coordinately regulate actin and microtubule dynamics and ultimately facilitates the metabolic reprogramming of T cells. Loss of SSH1 disorganizes IS in terms of mitochondria, rewiring T cells toward fatty acid oxidation, congregating lipid droplets and peroxisomes, and preventing glucose metabolism. Together, our findings establish SSH1 as a node connecting cytoskeletal dynamics to metabolic adaptation for T cell activation.

  • Open Access

    Selective genome editing of amplified oncogenes triggers immunogenic cell death and tumor remodeling

    by A. Nieto-Sanchez, M. Martinez-Lage, P. Puig-Serra, S. Carpintero, A. Alonso-Yanez, P. Ojeda-Walczuk, M. Ibañez-Navarro, G. Pita, Fj. Moya, C. Moreno, et al.

    Oncogene amplifications fuel some of the most lethal, therapy‑refractory cancers, yet remain clinically untargeted. We report a single‑guide CR


  • Open Access

    Editorial: Structure and function of the immunological and redirecting artificial synapses and their clinical implications

    by Manuel Izquierdo, Javier Ruiz-Navarro, Cosima T. Baldari, Pedro Roda-Navarro

    The immune system embraces a compendium of specialized cells, tissues, and organs that protect the organisms against a myriad of pathogens and can survey and destroy cancer cells. The recognition of the cognate antigens by the T cell and B cell receptor (TCR and BCR) that is required for the activation of antigen-specific effector functions of T and B lymphocytes is executed in the context of the immunological synapse (IS). The IS is a specialized cell-cell interaction, which acts as a signalling platform for the integration of signals leading to intercellular communication, in order to ensure efficient TCR and BCRevoked signal transduction IS formation triggers the asymmetric reorganization of actin and tubulin cytoskeleton, the convergence of secretory vesicles, including multivesicular bodies (MVB) (1) (2) and other lysosome-related organelles (LROs), towards the microtubule-organizing center (MTOC), which polarizes along with this vesicular content to the IS (3). These traffic events lead to the exocytosis of LROs and cytokine-containing vesicles at the synaptic cleft. LROs content secreted at the IS (including perforin, granzymes and intraluminal vesicles released as exosomes) has an important role on cytotoxic T lymphocyte (CTL) mediated cytotoxicity (3), activation-induced cell death (4), germinal center reaction and antibody production and antigen extraction at the B lymphocyte IS (5), whereas cytokine secretion plays an important role in antigen-presenting cell (APC) stimulation (6). In the framework of antigen recognition, MVB degranulation and extracellular vesicle (EV) secretion we have received a relevant review on microvilli and EVs at the IS (Ruiz-Navarro et al., https://doi.org/10.3389/fimmu.2023.1324557), This contribution dealt with the different EV classes detected at the IS, placing emphasis on the most recent findings on microvilli/lamellipodium-produced EVs. Microvilli connections are F-actinrich protrusions that act as sensors involved in palpating the antigen-presenting cells and in antigen sensing, and are fundamental initiators of IS assembly (7), however recent evidence supports an important role of microvilli not only in sensing antigen but also in effector functions by producing EVs. The signals leading to polarized secretion of EVs at the synaptic cleft were discussed, showing that the IS architecture fulfills a fundamental task in this secretion route. While significant attention has been focused on the T, B lymphocyte and NK cell side of the IS, particularly on its role as a secretory platform for polarized secretion of diverse secretory vesicles (8), much less is known about the traffic events occurring at the tumor cell side of the IS. Recent evidence supports the notion that tumor cells and APCs can rapidly reorganize their actin and tubulin cytoskeleton towards CTLs (9), Th cells (10) and NK cells (11). This reorganization underlies the polarized secretion of tumor cell LROs towards CTLs and NK cells, providing mechanisms that allow the tumor cell to evade the immune system (12). These results indicate that the vision of the IS based exclusively on analyses from the effector cell side of the synaptic cleft may only provide a partial view of the complex structural and functional interrelationship between the effector and the tumor cell. Indeed, a more holistic approach that should include the study of the events occurring at the tumor cell/APC side of the IS is needed to achieve a global picture of the IS structure and function. In this context, we have received an interesting contribution (Biolato et al., doi: 10.3389/fimmu.2024.1452810) on F-actin cytoskeleton reorganization in human breast adenocarcinoma cells and melanoma cells forming IS with human NK cells. The authors, using elegant super-resolution imaging approaches based on a pH-sensitive probe for CD63 + vesicle exocytosis, suggest that directed secretion may occur from tumor cells towards attacking NK cells. Their findings reveal that synaptic remodeling of the actin cytoskeleton within cancer cells engaged with NK cells is associated with an increased recruitment and fusion of MVBs at the IS, as was shown early at the T lymphocyte side of the IS (1) (2) (Ruiz-Navarro et al. https://doi.org/10.3389/fimmu.2023.1324557). This suggests that cancer cell-derived exosomes may be released into the IS, raising important questions about the properties of these exosomes and their potential role in conferring resistance to NK cell-mediated cytotoxicity. Although further investigation is needed to formally demonstrate IStriggered exosome secretion by the tumor cells, and to reveal both the mechanism involved and the consequences of MVBs secretory traffic, this contribution highlights a potentially overlooked mechanism by which cancer cells might evade immune destruction. Regarding translational implications that may be derived from applying such as holistic approach to IS studies, T-cell redirecting approaches to selectively eliminate tumor cells are useful strategies for cancer immunotherapy and are based in the formation of T celltarget cell conjugates (13), although these approaches have poor therapeutic results against solid tumors. These approaches include strategies to conjugate T lymphocytes with cancer cells using chimeric antigen receptors (CAR) (14) (15) or bispecific antibodies recognizing cell-surface tumor-associated antigens (16). Despite the fact that these two strategies promote the formation of functional ISs in terms of signals leading to LRO secretory polarized traffic and tumor cell death, the spatiotemporal architecture of the IS formed under these "artificial" redirecting strategies is different from that found in canonical, TCR-evoked synapses (13) (17). Canonical IS-tuned CAR signalling enhances anti-tumor activity of CAR T cells and T-cell engaging bispecific antibodies (17) (18), and recent evidence shows that IS quality measurements correlate with patient clinical...


  • Open Access

    Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase

    by Álvaro Gómez-Morón, Sergio Alegre-Gómez, Rocio Ramirez-Muñoz, Alicia Hernaiz-Esteban, Carlos Carrasco-Padilla, Camila Scagnetti, Óscar Aguilar-Sopeña, Marta García-Gil, Aldo Borroto, Raul Torres-Ruiz, et al.

    Actin dynamics control early T-cell receptor (TCR) signalling during T-cell activation. However, the precise regulation of initial actin rearrangements is not completely understood. Here, we have investigated the regulatory role of the phosphatase Slingshot-1 (SSH1) in this process. Our data show that SSH1 rapidly polarises to nascent cognate synaptic contacts and later relocalises to peripheral F-actin networks organised at the mature immunological synapse. Knockdown of SSH1 expression by CRISPR/Cas9-mediated genome editing or small interfering RNA reveal a regulatory role for SSH1 in CD3ε conformational change, allowing Nck binding and proper downstream signalling and immunological synapse organisation. TCR triggering induces SSH1-mediated activation of actin dynamics through a mechanism mediated by Limk-1 inactivation. These data suggest that during early TCR activation, SSH1 is required for rapid F-actin rearrangements that mediate initial conformational changes of the TCR, integrin organisation and proximal signalling events for proper synapse organisation. Therefore, the SSH1 and Limk-1 axis is a key regulatory element for full T cell activation.


  • Open Access

    T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase

    by Pedro Roda-Navarro, Álvaro Gómez-Morón, Sergio Alegre-Gómez, Rocio Ramirez-Muñoz, Alicia Hernaiz-Esteban, Carlos Carrasco-Padilla, Camila Scagnetti, Óscar Aguilar-Sopeña, Marta García-Gil, Aldo Borroto, et al.

    Actin dynamics control early T cell receptor signalling during T cell activation. However, the precise regulation of initial actin rearrangements is not completely understood. Here, we have investigated the regulatory role of the phosphatase Slingshot-1 (SSH1) in this process. Our data show that SSH1 rapidly polarises to nascent cognate synaptic contacts and later relocalises to peripheral F-actin networks organised at the mature synapses. Knockdown of SSH1 expression by CRISPR/Cas9-mediated genome editing or small interfering RNA revealed a regulatory role for SSH1 in CD3ε conformational change, allowing Nck binding and proper downstream signalling and immunological synapse organisation. TCR triggering induced the SSH1-mediated activation of actin dynamics through a mechanism mediated by Limk1 inactivation. These data suggest that during early TCR activation, SSH1 is required for early F-actin rearrangements that mediate initial conformational changes of the TCR, integrin organisation and proximal signalling events for proper synapse organisation.

  • Open Access

    Phosphatases of regenerating liver balance F-actin rearrangements during T cell activation through WD repeat containing protein 1

    by Óscar Aguilar-Sopeña, Carlos Carrasco-Padilla, Álvaro Gomez-Moron, Patricia Castro-Sánchez, Matías Estarás-Hermosel, Salvatore Valvo, Sergio Alegre-Gómez, Javier Redondo-Muñoz, Raúl Torres, Sandra Rodríguez-Perales, et al.

    Phosphatases of regenerating liver (PRLs) have been proposed to regulate actin dynamics in lymphoid cells. However, the mechanism mediating this role remained unknown. Here we showed the interaction of the PRLs with the actin regulator WD repeat containing protein 1 (WDR1). The interaction of the PRLs with WDR1 was dependent on F-actin integrity and the proper recruitment of the PRLs to cell membranes through the CAAX motif. Endogenous PRLs and WDR1 were distributed to the Immunological Synapse (IS) and perturbed expression of PRL-1 or PRL-2 by CRISPR/Cas9 mediated genome editing showed that the PRLs were required for proper distribution of WDR1 to filamentous (F)-actin at the IS. Further, perturbed expression of the PRLs or WDR1 resulted in defective IS assembly with deregulated F-actin rearrangements, altered positioning of LFA-1, and reduced IL-2 production. Interestingly, balanced expression of PRLs was required for accumulation of CD3ε at the IS and early activating signalling. We propose that PRLs regulate early T cell signalling and are required for proper F-actin dynamics by regulating the WDR1 access to F-actin networks. As a consequence, PRLs regulate LFA-1 positioning at the IS and proper cytokine secretion.

  • Activation kinetics of regulatory molecules during immunological synapse in T cells

    by Alvaro Gómez-Morón, Silvia Requena, Pedro Roda-Navarro, Noa Beatriz Martín-Cófreces


  • Open Access

    Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy

    by Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luis Álvarez-Vallina, Oscar Aguilar-Sopeña, Pedro Roda-Navarro

    T cell-redirecting strategies have emerged as effective cancer immunotherapy approaches. Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor microenvironment and induce the assembly of the immunological synapse (IS) between T cells and cancer cells or antigen-presenting cells. The way that the quality of the IS might predict the effectiveness of T cell-redirecting strategies, including those mediated by bsAbs or by chimeric antigen receptors (CAR)-T cells, is currently under discussion. Here we review the organization of the canonical IS assembled during natural antigenic stimulation through the T cell receptor (TCR) and to what extent different bsAbs induce T cell activation, canonical IS organization, and effector function. Then, we discuss how the biochemical parameters of different formats of bsAbs affect the effectivity of generating an antigen-induced canonical IS. Finally, the quality of the IS assembled by bsAbs and monoclonal antibodies or CAR-T cells are compared, and strategies to improve bsAb-mediated T cell-redirecting strategies are discussed.


  • T cell activation and effector function in the human Jurkat T cell model

    by C Carrasco-Padilla, O Aguilar-Sopeña, Alvaro Gómez-Morón, S Alegre-Gómez, Francisco Sánchez-Madrid, Noa Beatriz Martín-Cófreces, Pedro Roda-Navarro


  • Open Access

    Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients

    by Eva M. García-Cuesta, José Miguel Rodríguez-Frade, Sofía R. Gardeta, Gianluca D’aGostino, Pablo Martínez, Blanca Soler Palacios, Graciela Cascio, Tobias Wolf, Nicolas Mateos, Rosa Ayala-Bueno, et al.

    Significance: New imaging-based approaches are incorporating new concepts to our knowledge of biological processes. The analysis of receptor dynamics involved in cell movement using single-particle tracking demonstrates that cells require chemokine-mediated receptor clustering to sense appropriately chemoattractant gradients. Here, we report that this process does not occur in T cells expressing CXCR4 R334X , a mutant form of CXCR4 linked to WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis). The underlaying molecular mechanism involves inappropriate actin cytoskeleton remodeling due to the inadequate β-arrestin1 activation by CXCR4 R334X , which alters its lateral mobility and spatial organization. These defects, associated to CXCR4 R334X expression, contribute to the retention of hematopoietic precursors in bone marrow niches and explain the severe immunological symptoms associated with WHIM syndrome.